Herpes Eye Disease

Beck, Roy W.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Eye Institute (NEI)
• Type: Cooperative Clinical Research--Cooperative Agreements (U10)
• Project #: 3U10EY009687-03S1
• Application #: 2163372
• Study Section: Vision Research and Training Committee (VSN)
• Project Start: 1992-08-07
• Project End: 1997-07-31
• Budget Start: 1994-08-01
• Budget End: 1995-07-31
• Support Year: 3
• Fiscal Year: 1995

Institution

• Name: Jaeb Center for Health Research, Inc.
• DUNS #: 957043193
• City: Tampa
• State: FL
• Country: United States
• Zip Code: 33647

Publications

Lairson, David R; Begley, Charles E; Reynolds, Thomas F et al. (2003) Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis. Arch Ophthalmol 121:108-12

(2001) Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group. Cornea 20:123-8

(2000) Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group. Arch Ophthalmol 118:1030-6

(2000) Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Herpetic Eye Disease Study Group. Arch Ophthalmol 118:1617-25

(1998) Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N Engl J Med 339:300-6

(1997) A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. The Herpetic Eye Disease Study Group. Arch Ophthalmol 115:703-12

Dawson, C R; Beck, R; Wilhelmus, K R et al. (1996) Herpetic eye disease study. You can help. Arch Ophthalmol 114:89-90